viO HealthTech

All set up for Decoding the Future of Women. #ovusense #womenshealthmatters

Will you be at #BioTrinity in London 23rd April? Come and listen to and meet up with our CEO, Rob Milnes in the Femtech R&D Spotlight in Science Track 2.

Delighted to have been invited to speak about viO HealthTech's ground breaking #ovusense clinical research into menstrual cycle patterns at?the OBN (UK) Ltd BioTuesday event next week 'A Spotlight on the Latest Research and Innovation in the Thriving FemTech Market' is sold out - a testament to the ever expanding interest in properly serving the health needs of 51% of the population! Other serious research-led innovation being presented on the evening from: >?Peony Li, Founder & CEO of?Jude >?Dr Terri Cooper, NACD.DC, Board Chair of?Verso Biosense >?Karolina Afors, CMO of?Medherant Limited >?Tess Isabelle Cosad, CEO & Co-founder of?Béa Fertility >?Jared Williams, Founder & CEO of?Evelyn Health >?Karli Büchling, Founder & CEO of?YONI HEALTH #femtech?#womenshealthmatters ?#ovusense #ovusensepro

viO HealthTech Partners with Ovum Health to Improve Access to Personalized Information at Home for Women Trying to Conceive and Manage Their Broader Health Today, viO HealthTech, the manufacturer of the #OvuSense women’s health screening and monitoring platform, and Ovum Health, a leading virtual women’s fertility health clinic licensed in eight US states and growing, announce a collaboration to provide patients with greater access to critical health data in managing their health. Supporting all women on their health journey, especially those living with Polycystic Ovarian Syndrome (PCOS), endometriosis, thyroid issues and menopause, patients will now have greater access to the world’s most accurate cycle monitor to make more informed decisions, with the support of Ovum’s clinical team members. ? Ovum will recommend the OvuSense platform to help its clinician’s support patients, using the OvuSense Pro clinician portal to help understand their patient’s health issues and manage their therapeutic intervention prior to and during a timed intercourse cycle. “We serve a reproductive-aged population seeking a healthy pregnancy but struggling with chronic health conditions often undertreated until they find us. The OvuSense data is undeniably helpful and the device the most affordable for those with insurance, including Medicaid and commercial insurance plans,” shared Alice Crisci, Co-Founder and CEO of Ovum Health. “By offering OvuSense to help our clinical team understand their patient’s unique cycle patterns, we aim to improve patient outcomes with a healthier pregnancy, achieved more quickly.”?? ? “Ovum Health is a wonderful new partner for viO, as the care they deliver very much shares our vision of understanding and treating the health needs of each woman, as an individual” offered Rob Milnes, CEO of viO HealthTech. “We’re proud to be recognized as the only 510(k) approved class II cycle monitor with 99% clinical accuracy in confirming ovulation, and cycle phases, and know that the unique cycle flags shown by our #ovusensepro clinician portal can further improve the expertise which Ovum brings to its patients on a daily basis.”? ? Building on the research-led mentality of both companies, the new partnership will also involve enhanced clinical research, and co-development of digital therapeutics building on the unique OvuSense Intellectual Property and Ovum’s recent implementation of the IBM WatsonX platform. Full press release available here:https://lnkd.in/ekBbFvqD

2023 was a ground breaking year for viO HealthTech, documenting clinical evidence for our new applications for #ovusense in #PCOS Management and #Miscarriage Avoidance, the conclusion of our crowdfunding round, and finalising our new women's health platform which will be launched in 2024. Our Chief Medical Officer, Kate Davies, and CEO, Rob Milnes, sat down at the end of the year to talk about our new developments and the state of the women's health market. Here's a brief extract from the discussion on the viO research into miscarriage and how #ovusensepro can help clinicians and their patients in avoiding it.

There's just a week to go on our crowdfunding campaign. Join us on our webinar to find out more: 12.30pm UK time, Thursday 30th November 2023 If you haven't pledged to our campaign yet, we're giving you the chance to join Rob Milnes, CEO, and Kate Davies, Chief Medical Officer to hear more about viO HealthTech's plans to transform women's health. Click here to register your interest: https://lnkd.in/e5NVZtBS Hurry - places on the webinar are limited - don't miss out on this opportunity to transform women's health together! Disclaimer:?Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more:?https://lnkd.in/d2pbNbb